ALDER BIOPHARMACEUTICALS INC's ticker is and the CUSIP is 014339AA3. A total of 1 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $12,230,000 | +138.0% | 11,000,000 | +100.0% | 0.02% | +150.0% |
| Q2 2019 | $5,139,000 | -61.7% | 5,500,000 | -60.7% | 0.01% | -63.6% |
| Q1 2019 | $13,434,000 | +62.6% | 14,000,000 | +35.6% | 0.02% | +46.7% |
| Q4 2018 | $8,264,000 | +57.1% | 10,328,000 | +110.6% | 0.02% | +66.7% |
| Q3 2018 | $5,260,000 | +3.0% | 4,905,000 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $5,107,000 | -6.0% | 4,905,000 | -16.5% | 0.01% | 0.0% |
| Q1 2018 | $5,431,000 | – | 5,877,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 52,517,000 | $50,131,000 | 4.53% |
| Mohican Financial Management, LLC | 1,250,000 | $1,196,000 | 3.90% |
| Redmile Group, LLC | 25,000,000 | $23,865,000 | 0.70% |
| WOLVERINE ASSET MANAGEMENT LLC | 32,195,000 | $30,920,000 | 0.42% |
| PFM Health Sciences, LP | 17,213,000 | $16,517,000 | 0.36% |
| SSI INVESTMENT MANAGEMENT LLC | 2,750,000 | $2,626,000 | 0.22% |
| Rock Springs Capital Management LP | 5,000,000 | $4,798,000 | 0.18% |
| Partner Investment Management, L.P. | 137,000 | $131,000 | 0.15% |
| PALISADE CAPITAL MANAGEMENT, LP | 4,000,000 | $3,830,000 | 0.12% |
| DAFNA Capital Management LLC | 250,000 | $240,000 | 0.10% |